AR084791A1 - Preparacion medica que genera iodo, metodo de preparacion de la misma y aposito que contiene dicha preparacion - Google Patents
Preparacion medica que genera iodo, metodo de preparacion de la misma y aposito que contiene dicha preparacionInfo
- Publication number
- AR084791A1 AR084791A1 ARP120100035A ARP120100035A AR084791A1 AR 084791 A1 AR084791 A1 AR 084791A1 AR P120100035 A ARP120100035 A AR P120100035A AR P120100035 A ARP120100035 A AR P120100035A AR 084791 A1 AR084791 A1 AR 084791A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- iodine
- source
- initiating agent
- acid
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 14
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 8
- 239000003795 chemical substances by application Substances 0.000 abstract 8
- 229910052740 iodine Inorganic materials 0.000 abstract 8
- 239000011630 iodine Substances 0.000 abstract 8
- 230000000977 initiatory effect Effects 0.000 abstract 5
- 150000003839 salts Chemical class 0.000 abstract 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 3
- 229920002674 hyaluronan Polymers 0.000 abstract 3
- 229960003160 hyaluronic acid Drugs 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 2
- 239000000499 gel Substances 0.000 abstract 2
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical class OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 abstract 2
- 230000029663 wound healing Effects 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 239000001177 diphosphate Substances 0.000 abstract 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical class [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 abstract 1
- 235000011180 diphosphates Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000835 fiber Substances 0.000 abstract 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 150000004694 iodide salts Chemical class 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 abstract 1
- 239000010410 layer Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 235000021317 phosphate Nutrition 0.000 abstract 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 abstract 1
- 239000011941 photocatalyst Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 239000002356 single layer Substances 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000009834 vaporization Methods 0.000 abstract 1
- 230000008016 vaporization Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/106—Halogens or compounds thereof, e.g. iodine, chlorite
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ20110003A CZ303548B6 (cs) | 2011-01-05 | 2011-01-05 | Zdravotní prípravek tvorící jód, zpusob jeho prípravy a bandáž, která jej obsahuje |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR084791A1 true AR084791A1 (es) | 2013-06-26 |
Family
ID=45688327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120100035A AR084791A1 (es) | 2011-01-05 | 2012-01-05 | Preparacion medica que genera iodo, metodo de preparacion de la misma y aposito que contiene dicha preparacion |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR084791A1 (cs) |
| CZ (1) | CZ303548B6 (cs) |
| WO (1) | WO2012092908A1 (cs) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2017003562A (es) * | 2014-09-19 | 2017-10-04 | Galia Textil | Sustratos secos impregnados para un material para vendajes, método y sistema para la fabricación de los mismos. |
| WO2016179575A1 (en) | 2015-05-07 | 2016-11-10 | Kci Liensing, Inc. | A controlled release iodine structure for use with wound care |
| CZ2017320A3 (cs) * | 2017-06-05 | 2019-01-16 | Contipro A.S. | Antimikrobiální kompozice obsahující polysacharid, stabilizátor a trijodid, způsob její přípravy a použití |
| CN108208354B (zh) * | 2018-01-18 | 2021-03-23 | 仲恺农业工程学院 | 一种缓慢释放碘酸钙的微球及其制备方法 |
| KR102012581B1 (ko) * | 2018-01-22 | 2019-08-20 | 주식회사 디알나노 | 메틸렌블루 혼합물을 포함하는 패치형 창상피복재 |
| CN108721328B (zh) * | 2018-06-09 | 2020-12-01 | 江苏海尔滋生物科技有限公司 | 几丁聚糖碘生物材料及其制备方法 |
| CZ308064B6 (cs) * | 2018-08-23 | 2019-12-04 | Contipro As | Kompozice obsahující jodid a derivát kyseliny hyaluronové s oxidačním účinkem, způsob její přípravy a použití |
| CN112057467B (zh) * | 2020-09-09 | 2021-07-16 | 湖南大学 | 一种磷化钙矿化的铁基金属有机框架化合物的制备方法及其在制备腺苷代谢调控药物中的应用 |
| CN112755050B (zh) * | 2020-12-31 | 2022-11-15 | 佛山市正典生物技术有限公司 | 一种具有高组分稳定性的不含醇含碘消毒剂及其制备方法 |
| CN116478001A (zh) * | 2023-02-21 | 2023-07-25 | 安徽科技学院 | 具有杀菌作用的碘酸钙基含能微球的制备及燃烧性能调节方法 |
| CN116271194B (zh) * | 2023-05-06 | 2024-01-12 | 南通大学 | 一种止血黏附自修复医用生物胶、制备方法与应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB382572A (en) * | 1931-05-16 | 1932-10-27 | Iodine Educational Bureau Inc | Improvements in or relating to surgical material |
| US4141973A (en) | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
| US5166331A (en) | 1983-10-10 | 1992-11-24 | Fidia, S.P.A. | Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same |
| IT1229075B (it) | 1985-04-05 | 1991-07-17 | Fidia Farmaceutici | Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico |
| DE3482812D1 (de) | 1983-10-11 | 1990-08-30 | Fidia Spa | Fraktionen von hyaluronsaeure mit pharmazeutischer aktivitaet, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen. |
| US4636524A (en) | 1984-12-06 | 1987-01-13 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
| US4582865A (en) | 1984-12-06 | 1986-04-15 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
| US4851521A (en) | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
| US5081106A (en) * | 1990-07-16 | 1992-01-14 | The Oregon Health Sciences University | Wound dressing protocol utilizing collagen gelatin formed with iodine |
| US5128136A (en) | 1990-07-16 | 1992-07-07 | The Oregon Health Sciences University | Wound healing kit comprised of gelable collagen |
| CA2256400A1 (en) | 1996-05-28 | 1997-12-04 | Brown University Research Foundation | Hyaluronan based biodegradable scaffolds for tissue repair |
| AU1693099A (en) * | 1998-01-06 | 1999-07-26 | Fujisawa Pharmaceutical Co., Ltd. | Solid preparation of iodophor and its manufacturing methods |
| EP1087800B1 (en) * | 1998-06-19 | 2003-08-06 | Oxibio, Inc. | Implantable medical device having anti-infective and contraceptive properties |
| GB9905663D0 (en) | 1999-03-12 | 1999-05-05 | Bristol Myers Squibb Co | Iodine preparation composition |
| EP1744769A1 (en) * | 1999-12-28 | 2007-01-24 | Symbollon Corporation | Non-staining topical iodine composition |
| CZ12015U1 (cs) * | 2002-01-18 | 2002-02-25 | Cpn Spol. S R.O. | Přípravek pro prevenci adheze bandáľe na ránu |
| DE602006010656D1 (de) | 2006-02-02 | 2010-01-07 | Euro Celtique Sa | Hydrogel für Wundbehandlung |
| GB0614278D0 (en) * | 2006-07-19 | 2006-08-30 | Insense Ltd | Hydrogen peroxide delivery system |
| JP2008266276A (ja) | 2007-04-18 | 2008-11-06 | Chuichi Kubo | 損傷皮膚修復用組成物 |
-
2011
- 2011-01-05 CZ CZ20110003A patent/CZ303548B6/cs not_active IP Right Cessation
-
2012
- 2012-01-04 WO PCT/CZ2012/000002 patent/WO2012092908A1/en active Application Filing
- 2012-01-05 AR ARP120100035A patent/AR084791A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ303548B6 (cs) | 2012-11-28 |
| CZ20113A3 (cs) | 2012-07-18 |
| WO2012092908A1 (en) | 2012-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR084791A1 (es) | Preparacion medica que genera iodo, metodo de preparacion de la misma y aposito que contiene dicha preparacion | |
| BR112017003302A2 (pt) | sal de adição de ácido do composto inibidor de trk | |
| AR121843A2 (es) | Formulación oftálmica y método para mejorar la presbicia | |
| BR112015027282A8 (pt) | formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet | |
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| BR112014016788A2 (pt) | composições de ácidos graxos poli-insaturados ômega-3 em forma de ácido livre, enriquecidas com dpa | |
| BR112018075682A2 (pt) | inibidores de papd5 e papd7 para tratamento de infecção pela hepatite b | |
| BR112016014481A2 (pt) | tratamento de câncer utilizando combinações de inibidores de erk e raf | |
| BR112016002465A2 (pt) | terapia da combinação para o tratamento de câncer | |
| WO2015095811A8 (en) | Combination therapy with neoantigen vaccine | |
| MX379357B (es) | Formulación farmacéutica para usarse en el tratamiento tópico de una úlcera crónica. | |
| BR112015012197A2 (pt) | terapia de combinação | |
| PE20170302A1 (es) | Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington | |
| EA201290833A1 (ru) | Применение амисульприда в качестве противорвотного средства | |
| BR112016002171A2 (pt) | método, composição estéril e injetável e método para preparar uma composição estéril e injetável | |
| BR112015014034A2 (pt) | inibidores de irak e usos dos mesmos | |
| BR112012027092A2 (pt) | métodos e composiões para reduzir ou impedir a calcificação vascular durante a terapia de diálise peritoneal | |
| AR090879A1 (es) | Acidos indanoiloxidihidrobenzofuranilaceticos | |
| MX362804B (es) | Composiciones acuosas de capsaicinoides que comprenden un analgésico y un vehículo acuoso, y uso de las mismas para el tratamiento del dolor. | |
| BR112015009504A2 (pt) | inibidores de rock | |
| RU2013150536A (ru) | Способ и топическая композиция для обработки ран, содержащая seaprose и его применение | |
| ME02405B (me) | Spojevi pirazola као inhibitori sglt1 | |
| BR112014010729A2 (pt) | métodos para tratamento de ataques de gota | |
| BR112015001056A2 (pt) | composto, composição farmacêutica, métodos para o tratamento de distúrbios mediados pela aldosterona, para o tratamento de doença ou uma condição, para o tratamento da síndrome metabólica, para o tratamento de uma doença fisiológica ou patológica e para o tratamento da doença renal crônica, insuficiência renal ou nefropatia diabética | |
| RU2011136311A (ru) | Фармацевтические композиции для обезвоживания, атрофии и удаления патологических тканей |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |